Company intelligence / Profile preview

Kerwin Medical Center

Dallas, Texas, United States

Ownership: Private
Development stage: Other

Overview

Kerwin Medical Center is a clinical research site specializing in Central Nervous System (CNS) studies with particular focus on Alzheimer's Disease and related dementias. The center conducts Phase 1-3 clinical trials and NIH-funded studies, including a Phase 4 study testing Aducanumab efficacy. The organization prioritizes enrollment of underrepresented populations, particularly Black and Hispanic communities, targeting at least 18% participation from these groups.

Therapeutic areas: Neurology
Industry: Contract Research Organization

Partnerships

Pinnacle Clinical ResearchGlobal Alzheimer's Platform FoundationDementia Care Warriors

Beyond the preview

Go deeper on Kerwin Medical Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kerwin Medical Center.

Explore the full profile